HSC Section 8_April 2017

Selected Section Materials by Author

Reiter R, Pickhard A, Sander S, Brosch S. Prognostic relevance of mucosal waves in patients with unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol . 2016; 125(4):331-335. EBM level 4

Richards AL, Sugumaran M, Aviv JE, et al. The utility of office-based biopsy for laryngopharyngeal lesions: comparison with surgical evaluation. Laryngoscope . 2015; 125(4):909-912. EBM level 4

Rosow DE, Sulica L. Laryngoscopy of vocal fold paralysis: evaluation of consistency of clinical findings. Laryngoscope . 2010; 120(7):1376-1382. EBM level 2

Simpson CB, May LS, Green JK, et al. Vibratory asymmetry in mobile vocal folds: is it predictive of vocal fold paresis? Ann Otol Rhinol Laryngol . 2011; 120(4):239-242. EBM level 4

Spataro EA, Grindler DJ, Paniello RC. Etiology and time to presentation of unilateral vocal fold paralysis. Otolaryngol Head Neck Surg . 2014; 151(2):286-293. EBM level 4

Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS. Clinical manifestations and treatment of idiopathic and Wegener granulomatosis-associated subglottic stenosis. JAMA Otolaryngol Head Neck Surg . 2013; 139(1):76-81. EBM level 4

Verma SP, Dailey SH. Office-based injection laryngoplasty for the management of unilateral vocal fold paralysis. J Voice . 2014; 28(3):382-386. EBM level 4

Wu AP, Sulica L. Diagnosis of vocal fold paresis: current opinion and practice. Laryngoscope . 2015; 125(4):904-908. EBM level 5

Yamauchi A, Yokonishi H, Imagawa H, et al. Vocal fold vibration in vocal fold atrophy: quantitative analysis with high-speed digital imaging. J Voice . 2015; 29(6):755-762. EBM level 2

Youssef TF, Ahmed MR. Treatment of clinically diagnosed laryngopharyngeal reflux disease. Arch Otolaryngol Head Neck Surg . 2010; 136(11):1089-1092. EBM level 1

Zeigler A, Verdolini Abbott K, Johns M, et al. Preliminary data on two voice therapy interventions in the treatment of presbyphonia. Laryngoscope . 2014; 124(8):1869-1876. EBM level 2b

Section 7: Neoplastic and Inflammatory Diseases of the Head and Neck

Agrawal A, Civantos FJ, Brumund KT, et al. [ (99m) Tc]Tilmanocept accurately detects sentinel lymph nodes and predicts node pathology status in patients with oral squamous cell carcinoma of the head and neck: results of a phase III multi-institutional trial. Ann Surg Oncol . 2015; 22(11):3708-3715. EBM level 1 Andtbacka RH, Agarwala SS, Ollila DW, et al. Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma. Head Neck . 2016; 38(12):1752-1758. EBM level 2

Badran K, Jani P, Berman L. Otolaryngologist-performed head and neck ultrasound: outcomes and challenges in learning the technique. J Laryngol Otol . 2014; 128(5):447-453. EBM level 3

Busch EL, Zevallos JP, Olshan AF. Gastroesophageal reflux disease and odds of head and neck squamous cell carcinoma in North Carolina. Laryngoscope . 2016; 126(5):1091-1096. EBM level 3

I - 4